366 related articles for article (PubMed ID: 20104743)
1. [Gene characterization of E6 and E7 gene of human papillomavirus of 15 cervical cancer in Beijing].
Ren Z; Wu HW; Song J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):88-90. PubMed ID: 20104743
[TBL] [Abstract][Full Text] [Related]
2. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
3. [Association between human papillomavirus (HPV) type 16 infection and E6/E7 gene variant and the cervical lesions in Beijing].
Yang YJ; Zhao J; Liao QP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):32-4. PubMed ID: 17429529
[TBL] [Abstract][Full Text] [Related]
4. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas.
Vaeteewoottacharn K; Jearanaikoon P; Ponglikitmongkol M
Anticancer Res; 2003; 23(2C):1927-31. PubMed ID: 12820481
[TBL] [Abstract][Full Text] [Related]
5. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers.
Choi BS; Kim SS; Yun H; Jang DH; Lee JS
J Med Virol; 2007 Apr; 79(4):426-30. PubMed ID: 17311337
[TBL] [Abstract][Full Text] [Related]
6. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
Chang CH; Chen TH; Hsu RC; Chou PH; Yang JJ; Hwang GY
J Clin Virol; 2005 Jan; 32(1):33-7. PubMed ID: 15572004
[TBL] [Abstract][Full Text] [Related]
9. [Sequence polymorphism of human papillomavirus type 16 E7 in cervical cancer].
Liu X; Liu GB; Pang ZJ; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1272-5. PubMed ID: 16234107
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
12. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.
Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E
Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China.
Wu Y; Chen Y; Li L; Yu G; He Y; Zhang Y
J Gen Virol; 2006 May; 87(Pt 5):1181-1188. PubMed ID: 16603519
[TBL] [Abstract][Full Text] [Related]
15. [Human papillomavirus 16E6 gene mutation in cervical carcinoma tissues].
Sun F; Ha XQ; Lv TD; Xing CP; Liu B; Cao XZ
Ai Zheng; 2009 May; 28(5):478-82. PubMed ID: 19624874
[TBL] [Abstract][Full Text] [Related]
16. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
17. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women.
Song YS; Kee SH; Kim JW; Park NH; Kang SB; Chang WH; Lee HP
Gynecol Oncol; 1997 Aug; 66(2):275-81. PubMed ID: 9264576
[TBL] [Abstract][Full Text] [Related]
18. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
19. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
[TBL] [Abstract][Full Text] [Related]
20. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
